Juliane Gust1,2, Colleen E Annesley3,4, Rebecca A Gardner3,4, Xiuhua Bozarth1,2. 1. Division of Pediatric Neurology, Department of Neurology, University of Washington, Seattle, Washington, U.S.A. 2. Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, U.S.A. 3. Division of Hematology-Oncology, Department of Pediatrics, University of Washington, Seattle, Washington, U.S.A.; and. 4. Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, U.S.A.
Abstract
INTRODUCTION: EEG patterns in chimeric antigen receptor T cell treatment-associated neurotoxicity (immune effector cell-associated neurotoxicity syndrome) have not yet been systematically studied. We tested the hypothesis that EEG background abnormalities in immune effector cell-associated neurotoxicity syndrome correlate with clinical signs of neurotoxicity. In addition, we describe ictal and interictal EEG patterns to better understand the natural history of immune effector cell-associated neurotoxicity syndrome-associated seizures. METHODS: EEGs were obtained in 19 of 100 subjects in a prospective cohort study of children and young adults undergoing CD19-directed chimeric antigen receptor T cell therapy. We classified the EEG background on a severity scale of 0 to 5 during 30-minute epochs. EEG grades were compared with neurotoxicity scored by Common Terminology Criteria for Adverse Events and Cornell Assessment of Pediatric Delirium scores. Descriptive analysis was conducted for ictal and interictal EEG abnormalities. RESULTS: EEG background abnormality scores correlated well with Common Terminology Criteria for Adverse Events neurotoxicity scores (P = 0.0022) and Cornell Assessment of Pediatric Delirium scores (P = 0.0085). EEG was better able to differentiate the severity of coma patterns compared with the clinical scores. The EEG captured electroclinical seizures in 4 of 19 subjects, 3 of whom had additional electrographic-only seizures. Seizures most often arose from posterior head regions. Interictal epileptiform discharges were focal, multifocal, or lateralized periodic discharges. No seizures or interictal epileptiform abnormalities were seen in subjects without previous clinical seizures. CONCLUSIONS: Continuous EEG monitoring is high yield for seizure detection in high-risk chimeric antigen receptor T cell patients, and electrographic-only seizures are common. Increasing severity of EEG background abnormalities correlates with increasing neurotoxicity grade.
INTRODUCTION: EEG patterns in chimeric antigen receptor T cell treatment-associated neurotoxicity (immune effector cell-associated neurotoxicity syndrome) have not yet been systematically studied. We tested the hypothesis that EEG background abnormalities in immune effector cell-associated neurotoxicity syndrome correlate with clinical signs of neurotoxicity. In addition, we describe ictal and interictal EEG patterns to better understand the natural history of immune effector cell-associated neurotoxicity syndrome-associated seizures. METHODS: EEGs were obtained in 19 of 100 subjects in a prospective cohort study of children and young adults undergoing CD19-directed chimeric antigen receptor T cell therapy. We classified the EEG background on a severity scale of 0 to 5 during 30-minute epochs. EEG grades were compared with neurotoxicity scored by Common Terminology Criteria for Adverse Events and Cornell Assessment of Pediatric Delirium scores. Descriptive analysis was conducted for ictal and interictal EEG abnormalities. RESULTS: EEG background abnormality scores correlated well with Common Terminology Criteria for Adverse Events neurotoxicity scores (P = 0.0022) and Cornell Assessment of Pediatric Delirium scores (P = 0.0085). EEG was better able to differentiate the severity of coma patterns compared with the clinical scores. The EEG captured electroclinical seizures in 4 of 19 subjects, 3 of whom had additional electrographic-only seizures. Seizures most often arose from posterior head regions. Interictal epileptiform discharges were focal, multifocal, or lateralized periodic discharges. No seizures or interictal epileptiform abnormalities were seen in subjects without previous clinical seizures. CONCLUSIONS: Continuous EEG monitoring is high yield for seizure detection in high-risk chimeric antigen receptor T cell patients, and electrographic-only seizures are common. Increasing severity of EEG background abnormalities correlates with increasing neurotoxicity grade.
Authors: Rebecca A Gardner; Olivia Finney; Colleen Annesley; Hannah Brakke; Corinne Summers; Kasey Leger; Marie Bleakley; Christopher Brown; Stephanie Mgebroff; Karen S Kelly-Spratt; Virginia Hoglund; Catherine Lindgren; Assaf P Oron; Daniel Li; Stanley R Riddell; Julie R Park; Michael C Jensen Journal: Blood Date: 2017-04-13 Impact factor: 22.113
Authors: Arjan Roest; Bart van Bets; Philippe G Jorens; Ingrid Baar; Joost Weyler; Rudy Mercelis Journal: Neurocrit Care Date: 2009-01-07 Impact factor: 3.210
Authors: Aaron F Struck; Berk Ustun; Andres Rodriguez Ruiz; Jong Woo Lee; Suzette M LaRoche; Lawrence J Hirsch; Emily J Gilmore; Jan Vlachy; Hiba Arif Haider; Cynthia Rudin; M Brandon Westover Journal: JAMA Neurol Date: 2017-12-01 Impact factor: 18.302
Authors: Eric Azabou; Eric Magalhaes; Antoine Braconnier; Lyria Yahiaoui; Guy Moneger; Nicholas Heming; Djillali Annane; Jean Mantz; Fabrice Chrétien; Marie-Christine Durand; Frédéric Lofaso; Raphael Porcher; Tarek Sharshar Journal: PLoS One Date: 2015-10-08 Impact factor: 3.240
Authors: Alexander Shimabukuro-Vornhagen; Philipp Gödel; Marion Subklewe; Hans Joachim Stemmler; Hans Anton Schlößer; Max Schlaak; Matthias Kochanek; Boris Böll; Michael S von Bergwelt-Baildon Journal: J Immunother Cancer Date: 2018-06-15 Impact factor: 13.751
Authors: Shakira J Grant; Alyssa A Grimshaw; Juliet Silberstein; Donna Murdaugh; Tanya M Wildes; Ashley E Rosko; Smith Giri Journal: Transplant Cell Ther Date: 2022-03-11
Authors: Lila D Faulhaber; Anthea Q Phuong; Kendra Jae Hartsuyker; Yeheun Cho; Katie K Mand; Stuart D Harper; Aaron K Olson; Gwenn A Garden; Andy Y Shih; Juliane Gust Journal: Brain Commun Date: 2021-12-31
Authors: Isabelle Beuchat; Husain H Danish; Daniel B Rubin; Caron Jacobson; Matthew Robertson; Henrikas Vaitkevicius; Jong Woo Lee Journal: Neuro Oncol Date: 2022-02-01 Impact factor: 13.029